| Primary |
| Schizophrenia |
50.1% |
| Schizophrenia, Paranoid Type |
11.2% |
| Psychotic Disorder |
9.5% |
| Bipolar Disorder |
6.4% |
| Schizoaffective Disorder |
3.4% |
| Anxiety |
3.2% |
| Bipolar I Disorder |
2.8% |
| Product Used For Unknown Indication |
2.6% |
| Hiv Infection |
1.7% |
| Diabetes Mellitus |
1.5% |
| Depression |
1.1% |
| Insomnia |
1.1% |
| Affective Disorder |
0.8% |
| Agitation |
0.8% |
| Constipation |
0.8% |
| Mental Disorder |
0.8% |
| Attention Deficit/hyperactivity Disorder |
0.6% |
| Cardiac Failure |
0.6% |
| Decreased Appetite |
0.6% |
| Delusional Disorder, Unspecified Type |
0.6% |
|
| Somnolence |
21.6% |
| Sedation |
13.8% |
| Tachycardia |
10.6% |
| Speech Disorder |
5.0% |
| Tremor |
5.0% |
| Completed Suicide |
4.6% |
| Psychotic Disorder |
4.6% |
| Syncope |
4.1% |
| Fatigue |
3.2% |
| Hypertension |
2.8% |
| Injection Site Abscess |
2.8% |
| Malaise |
2.8% |
| Overdose |
2.8% |
| Prescribed Overdose |
2.8% |
| Confusional State |
2.3% |
| Dizziness |
2.3% |
| Off Label Use |
2.3% |
| Subcutaneous Abscess |
2.3% |
| Suicide Attempt |
2.3% |
| Tongue Paralysis |
2.3% |
|
| Secondary |
| Schizophrenia |
40.0% |
| Schizophrenia, Paranoid Type |
13.2% |
| Psychotic Disorder |
9.8% |
| Product Used For Unknown Indication |
7.7% |
| Bipolar Disorder |
5.5% |
| Irritability |
5.1% |
| Bipolar I Disorder |
4.3% |
| Delusional Disorder, Unspecified Type |
3.4% |
| Anxiety |
2.6% |
| Diabetes Mellitus |
1.7% |
| Insomnia |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Personality Disorder |
0.9% |
| Schizoaffective Disorder |
0.9% |
| Aggression |
0.4% |
| Anticoagulant Therapy |
0.4% |
| Blood Cholesterol |
0.4% |
| Depression |
0.4% |
| Extrapyramidal Disorder |
0.4% |
| Mental Disorder |
0.4% |
|
| Somnolence |
21.1% |
| Tachycardia |
10.1% |
| Myoclonus |
7.3% |
| Sedation |
6.4% |
| Sleep Disorder |
5.5% |
| Tongue Paralysis |
5.5% |
| Tremor |
5.5% |
| Weight Increased |
5.5% |
| Completed Suicide |
4.6% |
| Prescribed Overdose |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Confusional State |
2.8% |
| Metabolic Syndrome |
2.8% |
| Overdose |
2.8% |
| Schizophrenia |
2.8% |
| Urinary Incontinence |
2.8% |
| Fatigue |
1.8% |
| Injection Site Infection |
1.8% |
| Irritability |
1.8% |
| Lethargy |
1.8% |
|
